On March 10, 2022, Chinese biopharmaceutical company I-Mab saw its share price drop by nearly 14 percentage points in U.S. stock exchange markets, while Zai Lab similarly saw its share price decrease by some nine percentage points. This statistc illustrates the share price change in select Chinese companies listed in the United States.
Share price change in select Chinese biopharmaceutical companies listed in the United States on March 10, 2022
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Evaluate Vantage. (March 11, 2022). Share price change in select Chinese biopharmaceutical companies listed in the United States on March 10, 2022 [Graph]. In Statista. Retrieved December 22, 2024, from https://www.statista.com/statistics/1301169/us-listed-chinese-biopharma-share-price-change/
Evaluate Vantage. "Share price change in select Chinese biopharmaceutical companies listed in the United States on March 10, 2022." Chart. March 11, 2022. Statista. Accessed December 22, 2024. https://www.statista.com/statistics/1301169/us-listed-chinese-biopharma-share-price-change/
Evaluate Vantage. (2022). Share price change in select Chinese biopharmaceutical companies listed in the United States on March 10, 2022. Statista. Statista Inc.. Accessed: December 22, 2024. https://www.statista.com/statistics/1301169/us-listed-chinese-biopharma-share-price-change/
Evaluate Vantage. "Share Price Change in Select Chinese Biopharmaceutical Companies Listed in The United States on March 10, 2022." Statista, Statista Inc., 11 Mar 2022, https://www.statista.com/statistics/1301169/us-listed-chinese-biopharma-share-price-change/
Evaluate Vantage, Share price change in select Chinese biopharmaceutical companies listed in the United States on March 10, 2022 Statista, https://www.statista.com/statistics/1301169/us-listed-chinese-biopharma-share-price-change/ (last visited December 22, 2024)
Share price change in select Chinese biopharmaceutical companies listed in the United States on March 10, 2022 [Graph], Evaluate Vantage, March 11, 2022. [Online]. Available: https://www.statista.com/statistics/1301169/us-listed-chinese-biopharma-share-price-change/
